Sign in

NCT07063563Completed

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patients

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in Patients With COPD

Source: ClinicalTrials.gov · Last updated 11 Sept 2026

Brief summary (registry, in English)

Airway resistance will be measured using the forced oscillation technique (FOT). The parameters Rrs, Xrs, and ∆Xrs will be compared before and after a pulmonary rehabilitation cycle at moderate altitude. Additionally, the differences between low and moderate altitude will also be examined.

Status (registry)
Completed
Study type
Interventional
Enrollment
52 (actual)
First submitted
3 Jul 2025
Start date
23 Jul 2025
Primary completion date
31 Dec 2025
Lead sponsor
Eastern Switzerland University of Applied Sciences
Diseases
COPD
NCT number
NCT07063563

What you commit to

  • Study type: Interventional
  • Participants enrolled: 52
  • From 23 Jul 2025 to the primary completion date, 31 Dec 2025
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Long-term oxygen therapy

Other illness

  • Unstable clinical condition requiring adjustment of pharmacological or other treatment modalities, need for intensive care, or presence of relevant severe comorbidities
  • Inability to comply with study procedures (e.g., due to language barriers, psychological disorders, neurological or orthopedic impairments, walking disability, or inability to ride a bicycle)

Other

  • Severe daytime resting hypoxemia (SpO₂ \<88%)
  • Women who are pregnant or breastfeeding
  • Enrolment in another clinical trial involving active treatment

Who the study is looking for

  • Aged ≥18 years
  • Stable clinical condition for \>3 weeks (e.g., no exacerbations)
  • Resting SpO₂ ≥88% and exercise-induced hypoxemia defined as a drop in SpO₂ of ≥4% and/or a level below 90% during the 6MWT
  • Informed consent documented by signature

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Eastern Switzerland University of Applied Sciences
Coordinator of this site? Confirm its status
Sankt GallenSwitzerlandUnknown status
National center for cardiology and internal medicine
Coordinator of this site? Confirm its status
BishkekKyrgyzstanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.